Anzeige
Erschienen in:
14.09.2018 | Gynecologic Oncology
Predicting cervical intraepithelial neoplasia recurrence in HIV-infected and -noninfected women by detecting aberrant promoter methylation in the CDH1, TIMP3, and MGMT genes
Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 5/2018
Einloggen, um Zugang zu erhaltenAbstract
Purpose
Aberrant DNA methylation is present in virtually all types of human cancer. There is no clear evidence that methylation status can predict bad prognosis in patients with CIN recurrence in HIV infected. This study evaluates the relationship between aberrant methylation of CpG islands of CDH1, TIMP3 and MGMT genes and CIN recurrence in HIV-infected and -noninfected women.
Methods
This is a nested case–control study involving 33 cases with CIN recurrence and 114 controls without recurrence, HIV infected and noninfected, treated with LEEP, between 1999 and 2004. Recurrence diagnosis was established after biopsy. Genes methylation profile was assessed by MSP-PCR technique in formalin-fixed, paraffin-embedded cone specimens. Statistical analysis was performed to compare categorical variables, using χ2 test with Yates correction and Fisher’s exact test. Multivariate analysis was carried out using logistic regression.
Results
CIN recurrence was more frequent in women with glandular involvement (OR 11.6; 95% CI 2.93–45.89) and compromised surgical margins (OR 2.5; 95% CI 0.87–7.27) in the cervical cone and in HIV-infected women (OR 2.47; 95% CI 0.87–7.05). One methylated allele of CDH1, TIMP3 and MGMT genes was present in 87.9% women with CIN recurrence. Promoter hypermethylation of TIMP3 and MGMT was detected in women with CIN recurrence and without CIN recurrence independent of HIV infection with significant difference between groups (p = 0.04 and p = 0.02, respectively).
Conclusions
CIN recurrence was associated with glandular involvement and compromised margins in cone biopsy and HIV infection. The presence of CpG islands hemimethylation in TIMP3 and MGMT genes is a promising triage method in CIN recurrence.